We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · September 22, 2021

Anti-M3R Autoantibodies for Identifying Patients With Primary Sjögren's Syndrome

Clinical and Experimental Rheumatology


Additional Info

Clinical and Experimental Rheumatology
Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjögren's syndrome
Clin. Exp. Rheumatol. 2021 Aug 07;39(4)795-803, M Mona, S Mondello, JY Hyon, W Saleh, K Han, HJ Lee, YJ Ha, EH Kang, YJ Lee, S Cha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading